Therapeutic Classes/Glucose-dependent Insulinotropic Polypeptide Receptor Agonist

Glucose-dependent Insulinotropic Polypeptide Receptor Agonist

12 drugs across 1 manufacturer|0 Generic,12 Brand

The Glucose-dependent Insulinotropic Polypeptide Receptor Agonist class contains 12 NDCs from 1 manufacturer (0 generic, 12 brand), at an average NADAC of $532.28 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.

Total Drugs

12

0G / 12B

Manufacturers

1

Avg $532.2773/unit

Avg 7d Change

-0.04%

Across 11 drugs with changes

7d Activity

6↑5↓1 flat

of 12 total drugs

Class Price Trend

Monthly average NADAC price per unit, split by generic and brand

Manufacturer Breakdown

1 manufacturer producing drugs in this therapeutic class

Drug Portfolio

12 drugs total, 12 shown

WatchDrug ↕Price 7d Change ↕
MOUNJARO 10 MG/0.5 ML PEN
tirzepatide
$538.8259
per ML
+0.01%
MOUNJARO 2.5 MG/0.5 ML PEN
tirzepatide
$538.8104
per ML
+0.01%
MOUNJARO 7.5 MG/0.5 ML PEN
tirzepatide
$538.8009
per ML
+0.01%
MOUNJARO 5 MG/0.5 ML PEN
tirzepatide
$538.7628
per ML
+0.01%
MOUNJARO 12.5 MG/0.5 ML PEN
tirzepatide
$538.6401
per ML
+0.01%
MOUNJARO 15 MG/0.5 ML PEN
tirzepatide
$538.6287
per ML
+0.01%
ZEPBOUND 2.5 MG/0.5 ML PEN
tirzepatide
$526.2183
per ML
0.00%
ZEPBOUND 7.5 MG/0.5 ML PEN
tirzepatide
$525.8177
per ML
-0.04%
ZEPBOUND 5 MG/0.5 ML PEN
tirzepatide
$525.8145
per ML
-0.05%
ZEPBOUND 10 MG/0.5 ML PEN
tirzepatide
$525.7493
per ML
-0.06%
ZEPBOUND 15 MG/0.5 ML PEN
tirzepatide
$525.6651
per ML
-0.05%
ZEPBOUND 12.5 MG/0.5 ML PEN
tirzepatide
$525.5938
per ML
-0.05%

Follow this class across the site

These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.

Frequently Asked Questions

How many drugs are in the Glucose-dependent Insulinotropic Polypeptide Receptor Agonist class?

The Glucose-dependent Insulinotropic Polypeptide Receptor Agonist class contains 12 NDCs from 1 manufacturer — 0 generic and 12 brand products.

What is the average price of Glucose-dependent Insulinotropic Polypeptide Receptor Agonist drugs?

The average NADAC for the Glucose-dependent Insulinotropic Polypeptide Receptor Agonist class is $532.2773 per unit across 12 NDCs.

Which manufacturers make Glucose-dependent Insulinotropic Polypeptide Receptor Agonist drugs?

1 manufacturer makes drugs in the Glucose-dependent Insulinotropic Polypeptide Receptor Agonist class. Ranked by number of NDCs, the largest are Eli Lilly and Company (12).

How has Glucose-dependent Insulinotropic Polypeptide Receptor Agonist pricing changed recently?

Over the past 7 days, 6 NDCs in this class rose and 5 fell, with a class-wide average change of -0.0%.